title: Discontinued drugs in 2007: oncology drugs.
abstract: This perspective is part of an annual series of papers discussing drugs dropped from clinical development in the previous year. Specifically, this paper focuses on the 28 oncology drugs discontinued in 2007. Information for this perspective was derived from a search of the Pharmaprojects database for drugs discontinued after reaching Phase I - III clinical trials.
authors.affiliation: Head of Non-clinical Development Drug Development Office, Cancer Research UK, 61 Lincoln's Inn Fields, WC2A 3PX, London, UK. Robert.williams@cancer.org.uk
authors.forename: Robert
authors.initials: R
authors.lastname: Williams
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents